Back
Sarepta Therapeutics Stock Predictions
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
$118.99
Seasonality Move:
12.18%
7 Day Trial
ALL ACCESS PASS
$
7
The AI Energy Miracle
Details Here.Sarepta Therapeutics Stock Forecast
-
Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 37.6% based on the past 27 years of stock performance.
-
Sarepta Therapeutics has risen higher in 14 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.85%
-
Is Sarepta Therapeutics Stock Undervalued?The current Sarepta Therapeutics [SRPT] share price is $118.97. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Sarepta Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 37.6% based on the past 27 years of stock performance.
Sarepta Therapeutics Stock Rating
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics overpriced?
-
Sarepta Therapeutics has risen higher in 14 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.85%
Sarepta Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com
52-Week Data
52-Week High:
173.25
52-Week Low:
91.34
Prediction Charts
Market Cap:
11.4B
Price in USD:
118.97
Volume:
1.7M
Beta:
1.05
Technical Analysis
SMA50:
122.99
SMA100:
127.07
SMA200:
129.64
52-Wk Change:
31.76%
Stock Predictions
-
Is Sarepta Therapeutics stock public?Yes, Sarepta Therapeutics is a publicly traded company.
-
What is the Sarepta Therapeutics stock quote today?The Sarepta Therapeutics stock price is 118.97 USD today.
-
How to buy Sarepta Therapeutics stock online?You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 127.17 | 126.01 | 128.49 | 125.02 |
| Dec-4 | 126.01 | 126.53 | 127.96 | 124.81 |
| Dec-5 | 125.55 | 126.28 | 127.87 | 124.42 |
| Dec-6 | 126.34 | 128.17 | 129.06 | 125.52 |
| Dec-9 | 128.36 | 129.00 | 131.31 | 127.80 |
| Dec-10 | 129.08 | 126.70 | 129.37 | 126.00 |
| Dec-11 | 126.70 | 125.39 | 127.56 | 124.48 |
| Dec-12 | 125.39 | 124.47 | 126.72 | 123.74 |
| Dec-13 | 123.19 | 123.71 | 125.91 | 122.12 |
| Dec-16 | 123.46 | 126.79 | 128.73 | 123.00 |
| Dec-17 | 125.10 | 125.76 | 127.87 | 124.90 |
| Dec-18 | 126.04 | 120.25 | 126.04 | 119.84 |
| Dec-19 | 120.53 | 119.47 | 122.50 | 117.97 |
| Dec-20 | 119.59 | 118.97 | 121.00 | 118.56 |
Sarepta Therapeutics Earnings
Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sarepta Therapeutics Forecast Revenue Growth
Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.